ArticleBMC surgery2025
Analysis of risk factors for early mortality following hepatectomy in hepatocellular carcinoma patients.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrative systems biology and transcriptomic database analysis (GEPIA2 and TNMplot) uncover HRAS-driven anticancer mechanisms of anthraquinones in liver cancer.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Role of Liver Function in the Multiparametric Assessment of Hepatocellular Carcinoma.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to identify risk factors associated with early mortality (within 2 years) following hepatectomy in patients with hepatocellular carcinoma (HCC), with the goal of informing more rational treatment strategies.
methodsA retrospective analysis was conducted on clinical data from 236 HCC patients who underwent hepatectomy at the University of Hong Kong-Shenzhen Hospital between 2013 and 2021. Patients were categorized into early mortality (EM) and non-early mortality (NEM) groups based on survival status at 24 months post-surgery. Univariate and multivariable logistic regression analyses were employed to identify independent risk factors for early mortality. Based on the availability of clinical information, preoperative and early postoperative prediction models were developed, and corresponding nomograms were constructed. The predictive performance of the model was assessed using receiver operating characteristic (ROC) curves, and patients were stratified into different risk groups based on the predicted probabilities for further evaluation.
resultsIndependent risk factors for EM in the preoperative assessment included Child-Pugh grade B (P < .001), advanced BCLC staging (P = .010), and high Tumor burden score (TBS) (P < .001). For the early postoperative assessment, independent risk factors were Child-Pugh grade B (P < .001), high TBS (P < .001), non-Textbook Outcome (P < .001), and presence of Microvascular invasion (MVI) (P = .014). The preoperative model achieved an area under the ROC curve (AUC) of 0.832, while the postoperative model yielded an AUC of 0.865, indicating strong predictive performance. Stratification of patients based on predicted probabilities into distinct risk groups revealed statistically significant differences in both 2-year and 5-year survival rates, demonstrating robust risk-discriminatory ability.
conclusionBased on the availability of clinical information, this study identified independent risk factors associated with EM in both the preoperative and early postoperative phases, and constructed two nomograms to visualize the corresponding risks. Patients with multiple risk factors-particularly those deemed high-risk for EM (predicted probability > 66%) according to the nomogram-faced a significantly higher risk of early death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.